Thromboinflammation in Stroke Brain Damage-Reference-Cited by-同舟云学术

Thromboinflammation in Stroke Brain Damage

Published:2016-04 Issue:4 Volume:47 Page:1165-1172
ISSN:0039-2499
Container-title:Stroke
language:en
Short-container-title:Stroke

Author:

De Meyer Simon F.¹,Denorme Frederik¹,Langhauser Friederike¹,Geuss Eva¹,Fluri Felix¹,Kleinschnitz Christoph¹

Affiliation:

1. From the Laboratory for Thrombosis Research, KU Leuven Campus Kulak Kortrijk, Kortrijk, Belgium (S.F.D.M., F.D.); and Department of Neurology, University Clinic of Würzburg, Würzburg, Germany (F.L., E.G., F.F., C.K.).

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Advanced and Specialised Nursing,Cardiology and Cardiovascular Medicine,Clinical Neurology

Link

https://www.ahajournals.org/doi/pdf/10.1161/STROKEAHA.115.011238

Reference94 articles.

1. Ischemia and reperfusion—from mechanism to translation

2. Molecular mechanisms of thrombus formation in ischemic stroke: novel insights and targets for treatment

3. Combating innate inflammation: a new paradigm for acute treatment of stroke?

4. Platelets at work in primary hemostasis

5. von Willebrand Factor

Cited by 252 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nanocarriers' repartitioning of drugs between blood subcompartments as a mechanism of improving pharmacokinetics, safety, and efficacy;Journal of Controlled Release;2024-10

2. Electroacupuncture reduces inflammatory damage following cerebral ischemia–reperfusion by enhancing ABCA1-mediated efferocytosis in M2 microglia;Molecular Brain;2024-09-02

3. Development of machine learning-based models for predicting risk factors in acute cerebral infarction patients: a clinical retrospective study;BMC Neurology;2024-08-31

4. Huanglian Jiedu decoction alleviates ischemia‐induced cerebral injury in rats by mitigating NET formation and activiting GABAergic synapses;Journal of Cellular and Molecular Medicine;2024-08

5. Un anticorps monoclonal ciblant la glycoprotéine VI plaquettaire : une nouvelle génération d’antithrombotique sans risque hémorragique à la phase aiguë de l’infarctus cérébral;Bulletin de l'Académie Nationale de Médecine;2024-08